Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.
Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.
Newer treatments for type 2 diabetes are proving effective in the management of the disease, but their list of side effects continues to grow as more patients take the drugs over longer periods of time. According to Clinical Endocrinology News, the newer classes of diabetes drugs, which includes DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitors, have all been linked to potentially serious adverse effects to the skin. DPP-4 inhibitors, which include the brand names Januvia, Janumet and Tradjenta, have been linked to a condition known as bullous pemphigoid, a rare skin condition that causes large, fluid-filled blisters on areas of ... Read More
Upstart company Langford IC Systems claims its specialized washing machine can wash away deadly superbugs from medical equipment better that other cleaning and sterilizing processes currently in practice, and is the only system that meets Food and Drug Administration (FDA) standards for reprocessed medical devices. Ronald Reagan UCLA Medical Center in Los Angeles has stepped in to be the machine’s first buyer, testing the company’s claims on controversial duodenoscopes, a specialized endoscope that is fed down a person’s throat to treat or diagnose conditions affecting the duodenum. The devices have been blamed for spreading life-threatening CRE infections from patient to patient ... Read More
People who excessively used antibiotics over the course of their lives may be at greater risk of developing type 2 diabetes, a new study reveals. A team of researchers with Gentofte Hospital and the University of Southern Denmark made this observation after tracking antibiotic prescriptions for more than 170,000 people who had type 2 diabetes with 1.3 million people who did not have the disease. Researchers also found that people with type 2 diabetes who took more antibiotics as far back as 15 years prior to their diabetes diagnosis. The data also showed the risk was similar with all 16 ... Read More
Manufacturers of testosterone replacement therapies have been ordered by the Food and Drug Administration (FDA) to collect testosterone side effects data from men who use their drugs. To help speed up the process, the agency is encouraging the companies to “work together on a single trial.” The FDA request is the latest effort to crack down on the overprescribing of testosterone products. Thanks to heavy direct-to-consumer marketing campaigns by drug makers, prescriptions for “age-related hypogonadism” as opposed to “classic hypogonadism” have skyrocketed. Popular brand-name testosterone replacement therapies include AndroGel, Testim and Axiron. Hypogonadism, in the classic sense, is a condition in which ... Read More
E.H., a healthy 79-year-old man, is questioning whether he should take the new blood thinner Xarelto to treat occasional atrial fibrillation considering his history with bleeding events. “I hear it can be dangerous,” E.H. told Dr. Roach in a regular medical advice column in The Detroit News. “My doctors don’t seem worried, but I am.” E.H. says he has suffered from rectal bleeding in the past, “which wasn’t serious, but was scary.” He can’t even take aspirin because he’s prone to throwing up blood. He’s read enough about the new anticoagulant to question whether he should be concerned about taking ... Read More
Two researchers are spearheading an effort to reanalyze data involving the antipsychotic drug Risperdal after a lawsuit filed against Johnson & Johnson unit Janssen Pharmaceuticals claimed the company covered up side effects data in a 2003 study. Risperdal, known generically as risperidone, was approved by the Food and Drug Administration (FDA) in 1993 to treat adults with schizophrenia. Since then, it has been approved to treat schizophrenia, bipolar disorder and irritability with autism. The drug was granted pediatric use for those conditions in 2006. Drug regulators were reluctant to approve Risperdal for children because the medication can increase levels of the hormone ... Read More
A West Virginia woman is suing two doctors for improperly placing her Mirena intrauterine device (IUD), causing her to become pregnant and requiring her to undergo multiple surgeries. Melissa Cutter Johnson filed her lawsuit against Drs. Marcia A. Khalil and Gina Jereza-Harris. Her lawsuit also names Community Health Systems Inc. and Access Health-OB/GYN. According to her complaint, Johnson was implanted with the Mirena IUD at the medical center in September 2009, about three weeks after delivering a baby girl. The device helps prevent pregnancy for up to five years. However, Johnson became pregnant with twin daughters in September 2012. She ... Read More
The Food and Drug Administration (FDA) has approved the second drug in a novel new class of cholesterol-lowering drugs. Repatha (evolocumab) is an injectable medication that works by blocking a protein that interferes with the liver’s ability to remove so-called bad cholesterol – or LDL – from the blood. Last month, the FDA approved Praluent (alirocumab), also an injectable drug, was the first medication to be approved from the class, known as PCSK9 inhibitors. The drugs were highly anticipated treatments for patients with dangerously high levels of cholesterol and patients with high cholesterol who cannot tolerate the side effects caused ... Read More
Diabetes makes people more susceptible to several serious health conditions, but the disease can also be a pain in one’s wallet. “The cost of diabetes treatment has been increasing pretty rapidly,” says Glen Stettin, senior vice president for clinical, research and new solutions at Express Scripts. For four years straight, spending on diabetes treatments was higher per person than it was for any other class of traditional drug. Diabetics already pay about $5,000 more annually for their medications than people without the disease, according to a study by the Health Care Cost Institute, which examined insurance claims of nearly 40 ... Read More
Teleflex Medical is recalling a type of breathing tube after a complaint that the device has a defect that may cause it to leak, which could result in patients not getting enough oxygen and suffering respiratory distress, which could cause patient injury or death. The issue involves Teleflex Medical’s endobroncial tube’s double swivel connector, which can break or separate on the tube, causing the leak. An endobronchial tube is a plastic tube that is inserted through the mouth into the main passageway into the lungs, called the bronchi. The tube is used during a medical procedure called a bronchospirometry, which ... Read More